Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled Study Evaluating the Efficacy and Safety of MLC901 (NeuroAiD™ II) in Patients With Mild to Moderate Ischemic Stroke.

NCT07828210 is registered in ClinicalTrials.gov with EVD Pharmacy and Medical Company Limited as lead sponsor.

NCT NCT07828210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07828210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled Study Evaluating the Efficacy and Safety of MLC901 (NeuroAiD™ II) in Patients With Mild to Moderate Ischemic Stroke.
Lead sponsor
EVD Pharmacy and Medical Company Limited
Phase
Phase 4
Overall status
Recruiting
Start date
September 10, 2026
Completion date
December 31, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, stroke, acute ischemic, stroke, cardiovascular, stroke, cryptogenic, stroke, ischemic